[1] Sorbonne Univ, Med Oncol, Paris, France
[2] St Antoine Hosp, Paris, France
[3] GINECO, Med Oncol Dept, St Herblain, France
[4] Ctr Rene Gauducheau, Inst Cancerol lOuest, St Herblain, France
[5] Vall Hebron Inst Oncol VHIO, Vall DHebron Univ Hosp, Med Oncol, Barcelona, Spain
[6] Fdn Jimenez Diaz Hosp, START Madrid FJD, Clin Res, Madrid, Spain
[7] European Inst Oncol IRCCS, Div Early Drug Dev, IEO, Milan, Italy
[8] Univ Milan, Milan, Italy
[9] Hosp Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[10] Inst Catala Oncol, Med Oncol Serv, Girona, Spain
[11] BC Canc Kelowna, Med Oncol, Vancouver, BC, Canada
[12] BC Canc, Med Oncol, Vancouver, BC, Canada
[13] UCL, St Bartholomews Hosp London, Med Oncol, London, England
[14] Reg Ctr Oncol, Med Oncol, Gdansk, Poland
[15] Hosp Univ HM Sanchinarro, START Madrid CIOCC, Ctr Integral Oncol Clara Campal, Early Drug Dev Unit, Madrid, Spain
[16] IRCCS Ist Nazl Tumori Fdn, Med Oncol, Milan, Italy
[17] NYU Langone Hlth, Laura & Isaac Perlmutter Canc Ctr, Gynecol Oncol Grp GOG, Obstet & Gynecol, New York, NY USA
[18] Univ Hosp, Dept Med Oncol, Valencia, Spain
[19] Newcastle Hosp NHS Fdn Trust, Northern Ctr Canc Care, Med Oncol, Newcastle Upon Tyne, Tyne & Wear, England
[20] GlaxoSmithKline, Oncol Clin Dept, Waltham, MA USA
[21] GlaxoSmithKline, Clin Dev, Waltham, MA USA
[22] Royal Marsden Hosp NHS Fdn Trust, Gynaecol Dept, London, England